He is full professor in medicinal chemistry at the University of Milan. So far he has held several positions within international organizations and from 2013 to 2019 he was the director of the Summer School in Pharmaceutical analysis and since 2017 he is the Director of the Ph.D School in Pharmaceutical Sciences at the University of Milan. His main research interest is devoted to the development and application of high resolution mass spectrometric techniques in drug discovery and development. He is the author of more than 180 papers with an H index of 49 and he has been an invited speaker at several international congresses and seminars.

He holds a PhD degree in Chemistry and has a long experience in medicinal chemistry and drug discovery. He started his career in the industry working at the discovery of new drugs for Alzheimer’s disease. After moving to the Oncology area, he was appointed as project leader of discovery projects aiming at the search for antagonists of the αvβ3 integrin, tyrosine kinase inhibitors, and inhibitors of arginine methyltransferases. At IIT, he has continued his research activity focusing on the identification of new drugs for the treatment of inflammatory diseases and cystic fibrosis.

He studied biophysics at the University of Trento and trained at the Carnegie-Mellon University, The Scripps Research Institute, and the University of Lausanne. He joined Sandoz (now Novartis) in 1989 as lab head prior to his position in 1999 as head of the biomolecular NMR group at Pharmacia & Upjohn and then group leader at the Italian Institute of Technology. Afterwards he worked as NMR senior expert and associate professor at the University of Neuchâtel. His research interests are in NMR spectroscopy, from methodology development to its applications in chemistry and biology, fragment-based drug discovery and enzymology.

Master's Degree, Chemistry and Pharmaceutical Technology from Padua University. She has more than 20 years of experience in the Pharmaceutical Industry with a strong background in drug product development in particular for early phase projects. She started in GlaxoSmithKline as product development scientist focusing in biopharmaceutical aspects and assessment of oral dosage form starting from in vitro tools to predict in vivo performance. She moved in Aptuit in 2010 with main role of pharmaceutical development representative in international project teams, working mainly in multi-disciplinary integrated project teams as client interface. She is actually responsible for Pharmaceutical Development department involved in developing formulation from preclinical dosing to clinical manufacturing phase.

He got his Industrial Chemistry Degree in 1986. From 1998 he worked for SmithKline Beecham as Medicinal Chemist and Team Leader of the Delta Opioid Agonists Programme. In 1999 he was appointed Assistant Director Medicinal Chemistry Italy. In 2001 he co-founded NiKem Research a CRO for integrated medicinal chemistry services and was Director of DMPK and Developability Sciences. Presently he is COO and co-founder of Aphad, a CRO for pharmacokinetics and analytical services. He is author of more than 40 articles on international journals and 17 patents. He held lectures at several Italian Universities (Siena, Pavia, Genova, Pavia, Pisa and Milano).

He is Associate Professor at the University of Perugia (Italy). After studying organic synthesis, in 2005 he obtained his PhD in medicinal chemistry with Prof. Roberto Pellicciari. Antimo Gioiello has led several academic and industrial collaborations and his work experience spans various stages of early drug discovery in the area of liver and metabolic diseases. His main research interests include steroid chemistry, the discovery of NCEs for nuclear receptors, and the development of automated flow platforms for lead discovery and process chemistry. Antimo Gioiello is a co-founder of TES Pharma and member of the Board of Directors at the University of Perugia.

He got his Master’s Degree in Chemistry at the University of Ferrara and spent more than 19 years working in quantitative bioanalysis, regulatory guidelines and new technologies implementation. During his career he worked for GSK, APTUIT, Menarini and he is actually a Senior Research Leader for the Evotec Discovery DMPK department. He had also experience in outsourcing activities, due diligence support and is also an expert in lab automation, method development and problem solving. He is also author of publications in the bioanalytical and data integrity field.

Scientist at Accelera S.r.l. with a 20-year experience in bioanalysis. She grew up professionally thanks to her work in industries, such as Pharmacia, where she conducted her thesis in Medicinal Chemistry (CTF), Cell Therapeutics Inc. and Nerviano Medical Sciences. She has been involved in several bioanalytical activities concerning the quantitation of small molecules by LC-MS/MS, from early discovery to regulated development stages of drug research. Actually she has the role of study director. Her responsibilities span from the coordination of multisite projects to the planning, conducting and supervising of regulated preclinical and clinical studies.

She has a degree in Pharmaceutical Chemistry and Technology and a Master in Experimental Pharmacology (University of Milan). Since January 2007, she is Director of the Discovery Services Department at AXXAM, with the responsibility of the units of: Cell Biology, Biochemistry, Screening Technologies, Electrophysiology, High Content Screening, Molecular Biology, Cell Factory and iPSC. She is program director for many of the collaborations in place with national and international companies, as well as principal investigator for projects granted by the Italian government, the European Commission, and international organisms.

She met the Mass Spectrometry during her thesis in Organic Chemistry at the University of Pavia and never stopped working in that field since then. She had the opportunity to work in several pharmaceutical companies in Analytical Department group and as a support to research group always using Mass Spectrometry. She started with Bracco in 1996 using an ion trap to characterise synthetic compounds, move then to Zambon in 1998 to coordinate different activities in both analytical research and development but spent about 10 years in the company that was Pharmacia &Upjohn at the begininning and now is Nerviano Medical Sciences. When in P&U she met the HRMS used mainly to support the impurity profile among many other activities. In 2004 she decided to change her view and move to work in Waters as High-Resolution Mass Spectrometry (HRMS) specialist supporting customers in different application areas (from Met ID, to ADC characterization through small molecule structural ID).

He graduated in Pharmaceutical Technology and Chemistry in 1984 at Pisa University. His professional activity has been exerted in the fields of Medicinal and Analytical Chemistry. Presently, he is involved in the Menarini R&D Projects, mainly in structural elucidation of new drugs and their impurities, metabolites, biomolecules and natural products, through the use of advanced chromatographic and spectroscopic techniques, particularly GC-MS and LC-MS. Besides this, he exerts didactic activity in chromatography and mass spectrometry for Master and PhD courses. He is author of publications in pharmaceutical analysis, bioanalysis, medicinal chemistry and metabolite identification.

Degree in Pharmaceutical Chemistry (CTF) and Certified as Pharmacist at Università degli Studi di Padova. She has more than 15 years of experience in the Pharmaceutical Industry performing different roles in different regulated environments. She started in GMP quality assurance in GlaxoSmithKline Manufacturing as a microbiological specialist and then as a filling expert acquiring knowledge of GMP regulations applied to the production of cephalosporin for injection in a sterile environment. After two years she moved to the Bioanalytical department of GlaxoSmithKline R&D where she worked in a GLP environment, moving then to GLP/GCP QA. She now has the role of Manager of GLP/GCP quality assurance in Aptuit, an Evotec Company, responsible for all Quality Assurance GLP and GCP activities. Her responsibilities range from assuring Test Facility Management of compliance with GLP/GCP principles to provide regulatory support to the Business operations, to manage the validation of computerized systems, host Client and Regulatory inspections, collect and trend quality metrics.